Beijing Immupeutics Medicine Technology Limited
- Biotech or pharma, therapeutic R&D

At IMMUPEUTICS, we're driving the next revolution in cancer treatment. Our cutting-edge pipeline—featuring off-the-shelf mRNA vaccines, TCR bispecifics, and in vivo TCR-T therapies—is built for speed, scalability, and real-world impact. With exclusive access to a massive real-world library of tumor samples and patient data, we identify true tumor antigens and TCR targets faster and more accurately. The result? Smarter science, faster breakthroughs, and a bold leap forward in precision oncology. We’re now actively seeking strategic partners and investors to join us in accelerating this mission—and achieving success together.
Address
BeijingChina